nav-left cat-right
cat-right

Theravance Announces Initiation of Phase 1 Clinica...

Theravance, Inc. (NASDAQ: THRX) today announced that GlaxoSmithKline plc (GSK) initiated subject screening in a Phase 1 clinical study designed to assess the safety, tolerability, and pharmacokinetics of an investigational, inhaled bronchodilator, GSK1160724, for the treatment of chronic obstructive pulmonary disease (COPD). The compound was discovered by Theravance and is being developed by GSK under the parties’...

Mercury Therapeutics, Inc.: Breakthrough for Patie...

WOBURN, Massachusetts, November 26 /PRNewswire/ — Mercury Therapeutics, Inc. (MTI) has developed a novel lead generation platform to identify small molecule activators of protein kinases involved in the regulation of energy metabolism. The technology employed is in an interrelated series of in-vitro and cell-based protein kinase and cell metabolism assays that allow for the rapid filtering of the numerous hits that...

Antidepressant Found To Extend Lifespan In C. Eleg...

ScienceDaily (Nov. 22, 2007) — A team of scientists led by Howard Hughes Medical Institute (HHMI) investigator Linda B. Buck has found that a drug used to treat depression can extend the lifespan of adult roundworms. Buck and colleagues Michael Petrascheck and Xiaolan Ye report in the November 22, 2007, issue of the journal Nature, that the antidepressant drug mianserin can extend the lifespan of the nematode...

Aeolus Pharmaceuticals Provides Update on Pipeline...

LAGUNA NIGUEL, Calif.–(BUSINESS WIRE)–Aeolus Pharmaceuticals, Inc. (OTCBB:AOLS), announced today an update to its drug development activities. The Company is currently developing its drug candidates in the following indications; treatment of mustard gas exposure, radiation therapy, Parkinson’s Disease, colitis and Chronic Obstructive Pulmonary Disease. The Company has...
Page 34 of 34« First...1020...3031323334